Bruce is the Co-Founder and Chairman of the Board of Vittoria Biotherapeutics. During his 45-year career in biotechnology, Bruce has held numerous senior leadership positions, including President and Chief Executive Officer (CEO) at Adolor Corporation, Alba Therapeutics, and Orthovita, Inc., and Chief Financial Officer (CFO) and Chief Business Officer (CBO) of Ophthotech. For over 10 years, he served as Venture Partner with SV Life Sciences Health Investors. Previously, he was Executive Vice President and Chief Operating Officer (COO) of Cephalon Inc.; before this, he was CFO at Centocor, Inc. He recently served as interim COO of EyeBio guiding its $3B+ sale to Merck. Bruce is committed to nurturing young biotechnology companies in Philadelphia: he is also a co-founder of Carisma Therapeutics and Interius Biotherapeutics, companies focused on novel cell therapies for cancer.
